Naegleria fowleri explained

Naegleria fowleri, also known as the brain-eating amoeba, is a species of the genus Naegleria. It belongs to the phylum Percolozoa and is technically classified as an amoeboflagellate excavate,[1] rather than a true amoeba. This free-living microorganism primarily feeds on bacteria but can become pathogenic in humans, causing an extremely rare, sudden, severe, and usually fatal brain infection known as naegleriasis or primary amoebic meningoencephalitis (PAM).[2]

It is typically found in warm freshwater bodies such as lakes,[3] rivers, hot springs,[4] warm water discharge from industrial or power plants,[5] geothermal well water,[6] and poorly maintained or minimally chlorinated swimming pools with residual chlorine levels under 0.5 mg/m3,[7] [8] water heaters,[9] soil, and pipes connected to tap water.[10] It can exist in either an amoeboid or temporary flagellate stage.[11]

Etymology

The organism was named after Malcolm Fowler, an Australian pathologist at Adelaide Children's Hospital, who was the first author of the original series of case reports of PAM.[12] [13]

Life cycle

Naegleria fowleri, a thermophilic and free-living amoeba, is primarily found in warm and hot freshwater environments such as ponds, lakes, rivers, hot springs, and poorly maintained swimming pools.[14] As temperatures rise, its population tends to increase. Although the amoeba was initially identified in Australia in the 1960s, it is believed to have evolved in the United States.[15] N. fowleri exists in three forms: cyst, trophozoite (ameboid), and biflagellate. While it does not form cysts in solid human tissue, where only the amoeboid trophozoite stage is present, the flagellate form has been discovered in cerebrospinal fluid.

Cyst stage

To endure harsh environmental conditions, trophozoites transform into microbial cysts,[16] spherical, single-layered structures about 7–15 μm in diameter, enclosing a single cell nucleus.[17] Acting as a resilient capsule, the cyst enables the amoeba to withstand adverse circumstances. Factors triggering cyst formation include food scarcity, overcrowding, desiccation, waste accumulation, and cold temperatures. When conditions improve, the amoeba can emerge through the pore or ostiole at the center of the cyst. N. fowleri has been observed to encyst at temperatures below .

Trophozoite stage

The trophozoite stage is the infective phase for humans, during which the organism can actively feed and replicate. The trophozoite attaches to the olfactory epithelium, follows the axons of olfactory receptor neurons through the cribriform plate in the nasal cavity, and enters the brain. This reproductive stage of the protozoan organism transforms around, and thrives best at approximately, multiplying through binary fission.

Trophozoites are characterized by a nucleus surrounded by a flexible membrane. They move via pseudopodia, extending parts of their cell membrane (pseudopods) and filling them with protoplasm to facilitate locomotion. Pseudopods form in the direction of movement. In their free-living state, trophozoites feed on bacteria. In tissues, they appear to phagocytize (enclose and digest) red blood cells and cause tissue damage either through the release of cytolytic substances or by direct cell-to-cell contact using cytolytic membrane proteins.

As trophozoites, Naegleria fowleri may develop approximately 1 to 12 structures on their membrane known as amoebastomes (amorphous cytostomes), also referred to as "suckers" or "food cups," which they use for feeding in a manner similar to trogocytosis.[18]

Flagellate stage

The flagellate stage of Naegleria fowleri is pear-shaped and biflagellate (with two flagella). This stage can be inhaled into the nasal cavity, typically during activities such as swimming or diving. The flagellate form develops when trophozoites are exposed to a change in ionic strength in the fluid it is in, such as being placed in distilled water. The flagellate form does not exist in human tissue, but can be present in the cerebrospinal fluid. Once inside the nasal cavity, the flagellated form transforms into a trophozoite within a few hours.

Ecology

Naegleria fowleri, an excavate, inhabits soil and water. It is sensitive to drying and acidic conditions, and cannot survive in seawater. The amoeba thrives at moderately elevated temperatures, making infections more likely during summer months. N. fowleri is a facultative thermophile, capable of growing at temperatures up to .[11] Warm freshwater with an ample supply of bacteria as food provides a suitable habitat for amoebae. Locations where many amoebic infections have occurred include artificial bodies of water, disturbed natural habitats, areas with soil, and unchlorinated or unfiltered water.

N. fowleri appears to flourish during periods of disturbance. The "flagellate-empty" hypothesis suggests that Naegleria's success may stem from decreased competition when thermosensitive protozoal fauna do not survive changes in temperature. In other words, N. fowleri thrives when other predators consuming its food supply are absent. This hypothesis implies that human disturbances, such as thermal pollution, increase the abundance of N. fowleri by eliminating its resource competitors. Amoeboflagellates have a motile flagellate stage that aids in dispersal, that is advantageous in environments cleared of competing organisms.

Pathogenicity

See main article: Naegleriasis.

N. fowleri may cause a usually fatal infection of the brain called naegleriasis, primary amoebic meningoencephalitis (PAM), amoebic encephalitis/meningitis, or simply Naegleria infection. Infections most often occur when water containing N. fowleri is inhaled through the nose (aspirated), where it then enters the nasal and olfactory nerve tissue, travelling to the brain through the cribriform plate.[19] Swallowing contaminated water does not cause infection by N. fowleri.[20] Infections typically occur after swimming in warm-climate freshwater, although there have been cases in cooler climates such as Minnesota, US.[21] In rare cases, infection has been caused by nasal or sinus rinsing with contaminated water in a nasal rinsing device such as a neti pot. These account for 9% of worldwide cases.[22]

N. fowleri normally eat bacteria, but during human infections, the trophozoites consume astrocytes and neurons. The reason why N. fowleri passes across the cribriform plate is not known, but the neurotransmitter acetylcholine has been suggested as a stimulus precipitating the action, as a structural homolog of animal CHRM1 has been shown to be present in Naegleria and Acanthamoeba.[23]

The disease presents diagnostic challenges to medical professionals as early symptoms can be mild. 16% of cases presented with early flu-like symptoms only. Symptoms may also appear similar to a viral or bacterial meningitis which may delay correct diagnosis and treatment.[24] Most cases have been diagnosed post-mortem following a biopsy of patient brain tissue. [25] It takes one to twelve days, median five, for symptoms to appear after nasal exposure to N. fowleri flagellates.[26] Symptoms may include headache, fever, nausea, vomiting, loss of appetite, altered mental state, coma, drooping eyelid, blurred vision, and loss of the sense of taste.[27] Later symptoms may include stiff neck, confusion, lack of attention, loss of balance, seizures, and hallucinations. Once symptoms begin to appear, the patient usually dies within two weeks. N. fowleri is not contagious; an infected person cannot transmit the infection.

Primary amoebic meningoencephalitis is classified as a rare disease in the United States as it affects fewer than 200,000 people.[28] From 2013 to 2022, 29 infections were reported in the US, which compares with about 4,000 annual deaths by drowning.[29] It is so rare that individual cases are often reported internationally, with 381 cases reported globally.[30] The true number of cases is likely to be higher than those reported due to problems relating to diagnosis, access to diagnostic testing and a lack of surveillance.

Animals may be infected by Naegleria fowleri. This is rarely observed, although it may occur and be overlooked. Experimentally, mice, guinea pigs, and sheep have been infected, and there have been reports of South American tapirs and cattle contracting PAM.[31]

Treatment

The core antimicrobial treatment consists of the antifungal drug amphotericin B,[32] which inhibits the pathogen by binding to its cell membrane sterols, causing cell membrane disruption and pathogen death; however, even with this treatment, the fatality rate is greater than 97%.[29] [33] New treatments are being sought.[29] [34] Miltefosine, an antiparasitic drug that inhibits the pathogen via disrupting its cell survival signal pathway PI3K/Akt/mTOR,[35] has been used in a few cases with mixed results.[36] Other treatments include Dexamethasone and therapeutic hypothermia,[37] that may be utilised to reduce inflammation. Therapeutic hypothermia reduces the body's temperature to a hypothermic state [38] to prevent further brain injury resulting from hyper inflammation and increased intracranial pressure. [39]

A key factor to effective treatment is the speed of diagnosis. Naegleriasis is rare, and is often not considered as a likely diagnosis; therefore, the clinical laboratory's identification of the microorganism may be the first time an amoebic etiology is considered. Rapid identification can help to avoid delays in diagnosis and therapy. Amoeba cultures and real-time polymerase chain reaction (PCR) studies for N. fowleri are diagnostic of PAM, but they are not readily available at most institutions, and would have to be carried out at a reference laboratory. The time of presentation of the patient may affect the identification of the microorganism also, as PAM has an incubation period ranging from 1 to 12 days.[29] The clinical signs of PAM are similar to bacterial and viral meningitis, including fever, neck stiffness, and severe headaches. Symptoms can progress to prolonged nausea, vomiting, and even seizures. The disease can progress to acute hemorrhagic necrotizing meningoencephalitis. After symptoms start the patient typically dies within 1 to 18 days, typically about 5 days.[29] A variable delay in treatment can be secondary to time intervals in multiple stages of care, including exposure to exhibition of symptoms; arrival for treatment at a health care facility; workup of the diagnosis (initial diagnosis of likely bacterial meningitis); and finally, from diagnosis to initiation of recommended therapy. Successful treatment of PAM is rare; treatment can only be attempted after correct diagnosis, which relies on rapid recognition of the microorganism by medical technologists and pathologists. It is critical that medical technologists consistently provide timely CSF evaluation, explore the diagnosis of PAM, and look for amoebae in the setting of meningitis, especially in summer.[40]

Preventing human infection

A large proportion of reported cases of infection had a history of water exposure, 58% from swimming or diving, 16% from bathing, 10% from water sports such as jet skiing, water-skiing and wakeboarding and 9% from nasal irrigation. Methods of infection prevention therefore focus on precautions to be taken around water to prevent water entering the nose, particularly during warmer weather. Wearing a nose clip when swimming may help to prevent contaminated water travelling up the nasal cavity. Keeping the head above water and not jumping or diving into warm fresh water may also prevent contaminated water from going up the nose. Swimmers should also avoid digging or stirring up sediment at the bottom of lakes, ponds and rivers as this is where amebae are most likely to live.[41] [42]

When irrigating sinuses or taking part in ritual cleansing of the nasal cavity, it is advised to use boiled or distilled water.[43]

Cases in Pakistan and India

Cases of infection in Pakistan account for 11% of reported cases globally. In Pakistan, the number of reported cases has surpassed the global total due to insufficient healthcare infrastructure and limited awareness of Naegleria fowleri. As a result, only a small fraction of cases are correctly identified as primary amebic meningoencephalitis (PAM), with the majority of cases misdiagnosed as viral meningitis.

For the first time in Pakistan, N. fowleri genotype has been identified as type-2. Phylogenetic analysis showed that N. fowleri isolate from Pakistan is among the latest descendants, i.e., evolved later in life.[44]

Recent Cases in India

India has seen a significant rise in primary amoebic meningoencephalitis (PAM) cases in 2024. In Kerala, four cases were reported over two months, leading to three deaths, while a 14-year-old boy from Kozhikode made a rare recovery, defying the nearly 97% mortality rate.[45] His recovery was attributed to early detection and treatment using Miltefosine. Meanwhile, Kolkata has recorded six cases in a year, with one patient still being treated.[46] This increase has raised concerns, particularly given the infection’s 97% fatality rate. Health experts call for comprehensive studies to determine the reasons behind this sudden rise.

See also

External links

Notes and References

  1. 15313128 . 10.1016/j.ijpara.2004.06.004. Free-living amoebae as opportunistic and non-opportunistic pathogens of humans and animals . 2004 . Schuster . Frederick L. . Visvesvara . Govinda S. . International Journal for Parasitology . 34 . 9 . 1001–1027 .
  2. News: Texas residents warned of tap water tainted with brain-eating microbe . 27 September 2020 . . . 26 September 2020 . 27 September 2020 . https://web.archive.org/web/20200927000011/https://www.theguardian.com/us-news/2020/sep/26/texas-tap-water-tainted-brain-eating-microbe . live .
  3. Isolation and identification of pathogenic Naegleria from Florida lakes. . Appl Environ Microbiol . 1977 . 34 . 6 . 661–7 . 596870 . 242727 . 10.1128/AEM.34.6.661-667.1977 . 1977ApEnM..34..661W . Wellings . F. M. . Amuso . P. T. . Chang . S. L. . Lewis . A. L. .
  4. Sheehan. Kathy B.. Fagg. Jennifer A.. Ferris. Michael J.. Henson. Joan M.. PCR Detection and Analysis of the Free-Living Amoeba Naegleria in Hot Springs in Yellowstone and Grand Teton National Parks. Applied and Environmental Microbiology. 69. 10. 2003. 5914–5918. 10.1128/AEM.69.10.5914-5918.2003. 14532044. 201221. 2003ApEnM..69.5914S . free.
  5. Occurrence and pathogenicity of Naegleria fowleri in artificially heated waters. . Appl Environ Microbiol . 1983 . 45 . 3 . 974–9 . 6847189 . 242399 . 10.1128/AEM.45.3.974-979.1983. Sykora . J. L. . Keleti . G. . Martinez . A. J. . 1983ApEnM..45..974S .
  6. Marciano-Cabral. Francine. MacLean. Rebecca. Mensah. Alex. LaPat-Polasko. Laurie. Identification of Naegleria fowleri in Domestic Water Sources by Nested PCR. Applied and Environmental Microbiology. 69. 10. 2003. 5864–5869. 10.1128/AEM.69.10.5864-5869.2003. 14532037. 201236. 2003ApEnM..69.5864M . free.
  7. Yoder. J. S.. Eddy. B. A.. Visvesvara. G. S.. Capewell. L.. Beach. M. J.. The epidemiology of primary amoebic meningoencephalitis in the USA, 1962–2008. Epidemiology and Infection. 138. 7. 2009. 968–975. 10.1017/S0950268809991014. 19845995. 7828942. free.
  8. Maclean . RebeccaC. . Richardson . DennisJ. . LePardo . Robin . Marciano-Cabral . Francine . 2004 . The identification of Naegleria fowleri from water and soil samples by nested PCR . Parasitology Research . 93 . 3 . 211–217 . 10.1007/s00436-004-1104-x . 15138806 . 5972631.
  9. Yoder. J. S.. Straif-Bourgeois. S.. Roy. S. L.. Moore. T. A.. Visvesvara. G. S.. Ratard. R. C.. Hill. V. R.. Wilson. J. D.. Linscott. A. J.. Crager. R.. Kozak. N. A.. Sriram. R.. Narayanan. J.. Mull. B.. Kahler. A. M.. Schneeberger. C.. da Silva. A. J.. Poudel. M.. Baumgarten. K. L.. Xiao. L.. Beach. M. J.. Primary Amebic Meningoencephalitis Deaths Associated With Sinus Irrigation Using Contaminated Tap Water. Clinical Infectious Diseases. 55. 9. 2012. e79–e85. 10.1093/cid/cis626. 22919000. free. 11307261.
  10. Web site: 2023-05-03. Naegleria fowleri — Primary Amebic Meningoencephalitis (PAM): Ritual Nasal Rinsing & Ablution. CDC. www.cdc.gov. 2022-11-30. https://web.archive.org/web/20221130122745/https://www.cdc.gov/parasites/naegleria/ritual-ablution.html. live.
  11. Web site: Naegleria fowleri — Primary Amebic Meningoencephalitis (PAM): General Information. Centers for Disease Control and Prevention (CDC) . 2023-05-03. 2018-07-28 . https://web.archive.org/web/20180728050630/https://www.cdc.gov/parasites/naegleria/general.html . live .
  12. Fowler . M.. Carter, R. F. . Acute pyogenic meningitis probably due to Acanthamoeba sp.: a preliminary report . British Medical Journal . 2 . 5464 . 740–2 . September 1965 . 5825411 . 1846173 . 10.1136/bmj.2.5464.734-a.
  13. Web site: The discovery of amoebic meningitis in Northern Spencer Gulf towns . samhs.org . South Australian Medical Heritage Society Inc . August 15, 2019 . October 22, 2022 . https://web.archive.org/web/20221022121725/https://www.samhs.org.au/Virtual%20Museum/Medicine/amoeb-mening/amoebic-miningitis.htm . live .
  14. Laseke I, Korte J, Lamendella R, Kaneshiro ES, Marciano-Cabral F, Oerther DB . January 2010 . Identification of Naegleria fowleri in warm ground water aquifers . Journal of Environmental Quality . 39 . 1 . 147–153 . 10.2134/jeq2009.0062 . 6844256 . 20048302. 2010JEnvQ..39..147L .
  15. Web site: Brain-eating-amoeba . live . https://web.archive.org/web/20160821233242/http://www.webmd.com/brain/brain-eating-amoeba . 21 August 2016 . 1 July 2015 . WebMD.
  16. Chang . S.L. . 1978 . Resistance of pathogenic Naegleria to some common physical and chemical agents . Applied and Environmental Microbiology . 35 . 2 . 368–375 . 1978ApEnM..35..368C . 10.1128/AEM.35.2.368-375.1978 . 242840 . 637538.
  17. Marciano-Cabral . F . 1988 . Biology of Naegleria spp . Microbiological Reviews . 52 . 1 . 114–133 . 10.1128/MMBR.52.1.114-133.1988 . 372708 . 3280964.
  18. John . D T . Cole . T B . Marciano-Cabral . F M . January 1984 . Sucker-like structures on the pathogenic amoeba Naegleria fowleri . Applied and Environmental Microbiology . en . 47 . 1 . 12–14 . 1984ApEnM..47...12J . 10.1128/aem.47.1.12-14.1984 . 0099-2240 . 239603 . 6696410.
  19. Baig . AM . Aug 2015 . Pathogenesis of amoebic encephalitis: Are the amoebae being credited to an 'inside job' done by the host immune response? . Acta Trop. . 148 . 72–76 . 10.1016/j.actatropica.2015.04.022 . 25930186 .
  20. Web site: 2019-06-24. Primary Amebic Meningoencephalitis (PAM) - Naegleria fowleri Parasites CDC. 2020-10-16. www.cdc.gov. 2019-01-29. https://web.archive.org/web/20190129112234/https://www.cdc.gov/parasites/naegleria/index.html. live.
  21. Web site: Naegleria and Amebic Meningoencephalitis – Minnesota Dept. of Health. 2020-10-16. www.health.state.mn.us. 2022-12-28. https://web.archive.org/web/20221228121534/https://www.health.state.mn.us/diseases/naegleria/index.html. live.
  22. Gharpure . Radhika . Bliton . John . Goodman . Alexandra . Ali . Ibne Karim M . Yoder . Jonathan . Cope . Jennifer R . 2021-07-01 . Epidemiology and Clinical Characteristics of Primary Amebic Meningoencephalitis Caused by Naegleria fowleri : A Global Review . Clinical Infectious Diseases . en . 73 . 1 . e19–e27 . 10.1093/cid/ciaa520 . 1058-4838 . 8739754 . 32369575.
  23. Baig . AM . Aug 2016 . Primary Amoebic Meningoencephalitis: Neurochemotaxis and Neurotropic Preferences of Naegleria fowleri . ACS Chem Neurosci . 7 . 8. 1026–1029 . 10.1021/acschemneuro.6b00197 . 27447543 . free .
  24. Web site: 2023-05-03 . Illness and Symptoms Naegleria fowleri CDC . 2024-03-12 . www.cdc.gov . en-us.
  25. Güémez . Andrea . García . Elisa . 2021-09-06 . Primary Amoebic Meningoencephalitis by Naegleria fowleri: Pathogenesis and Treatments . Biomolecules . en . 11 . 9 . 1320 . 10.3390/biom11091320 . free . 2218-273X . 8469197 . 34572533.
  26. Web site: Naegleria fowleri – Primary Amebic Meningoencephalitis (PAM): Illness & Symptoms . Centers for Disease Control and Prevention (CDC) . live. May 3, 2023. https://web.archive.org/web/20200511072754/https://www.cdc.gov/parasites/naegleria/illness.html . May 11, 2020.
  27. Web site: Brain-Eating Amoeba (Naegleria Fowleri): FAQ, Symptoms, Treatment. 2021-09-29. WebMD. 2022-12-28. https://web.archive.org/web/20221228121534/https://www.webmd.com/brain/brain-eating-amoeba. live.
  28. Web site: 2023-05-03 . General Information Naegleria fowleri CDC . 2024-03-12 . www.cdc.gov . en-us.
  29. Web site: Frequently asked questions about Naegleria fowleri, commonly known as the "brain-eating ameba". live. . CDC.gov . Centers for Disease Control and Prevention (CDC) . May 3, 2023 . https://web.archive.org/web/20200513090557/https://www.cdc.gov/parasites/naegleria/general.html . May 13, 2020.
  30. News: Helmore . Edward . Arkansas child dies of rare brain-eating amoeba after playing at country club . The Guardian (UK). 19 September 2023 .
  31. Web site: Naegleria Fowleri in Animals. ldh.la.gov . 25 September 2013 . Infectious Disease Epidemiology Section, Office of Public Health, Louisiana Dept of Health & Hospitals. https://web.archive.org/web/20230205010344/https://ldh.la.gov/assets/oph/Center-PHCH/Center-CH/infectious-epi/EpiManual/NaegleriaFowleriInAnimalsManual.pdf . 5 February 2023 . live.
  32. Medscape . Nov 23, 2015 . Subhash Chandra Parija . Naegleria Infection Treatment & Management . https://web.archive.org/web/20191113203834/https://emedicine.medscape.com/article/223910-treatment . November 13, 2019 .
  33. Cetin . N . Blackall . D . April 2012 . Naegleria fowleri meningoencephalitis . Blood . 119 . 16. 3658 . 22645743 . 10.1182/blood-2011-06-353136 . 8912435 . free .
  34. Web site: Scientists scour the globe for a drug to kill deadly brain-eating amoeba. STAT. 22 July 2016. Wessel. Lindzi. 6 October 2020. https://web.archive.org/web/20201006042915/https://www.statnews.com/2016/07/22/brain-eating-amoeba/. live.
  35. Asbill . Scott . Virga . Kris . 2015 . Naegleria Fowleri: Pathogenesis, Diagnosis, and Treatment Options . Antimicrobial Agents and Chemotherapy . 59 . 11 . 6677–6681 . 26259797 . 10.1128/AAC.01293-15 . 4604384.
  36. Wessel . Linda . 16 September 2016 . A life-saving drug that treats a rare infection is almost impossible to find . Business Insider . https://web.archive.org/web/20160919150218/http://www.businessinsider.com/why-brain-eating-amoeba-miltefosine-medicine-is-hard-to-find-2016-9?amp . 19 September 2016 . live . dmy.
  37. Web site: 2023-05-03 . Treatment Naegleria fowleri CDC . 2024-03-12 . www.cdc.gov . en-us.
  38. Web site: 2023-05-03 . Treatment Naegleria fowleri CDC . 2024-03-12 . www.cdc.gov . en-us.
  39. Güémez . Andrea . García . Elisa . 2021-09-06 . Primary Amoebic Meningoencephalitis by Naegleria fowleri: Pathogenesis and Treatments . Biomolecules . en . 11 . 9 . 1320 . 10.3390/biom11091320 . free . 2218-273X . 8469197 . 34572533.
  40. Pugh. J. Jeffrey. Levy. Rebecca A.. 2016-09-21. Naegleria fowleri: Diagnosis, Pathophysiology of Brain Inflammation, and Antimicrobial Treatments. ACS Chemical Neuroscience. 7. 9. 1178–1179. 10.1021/acschemneuro.6b00232. 27525348. free.
  41. Web site: CDC . 2022-08-19 . Naegleria fowleri infections are rare. . 2024-03-12 . Centers for Disease Control and Prevention . en-us.
  42. Web site: 2022-10-18 . Pathogen and Environment Naegleria fowleri CDC . 2024-03-12 . www.cdc.gov . en-us.
  43. Web site: 2023-05-03 . Ritual Nasal Rinsing & Ablution Naegleria fowleri CDC . 2024-03-12 . www.cdc.gov . en-us.
  44. Aurongzeb . Muhammad . Rashid . Yasmeen . Ahmed Naqvi . Syed Habib . Khatoon . Ambrina . Abdul Haq . Sadia . Azim . Mohammad Kamran . Kaleem . Imdad . Bashir . Shahid . 2022 . Naegleria fowleri from Pakistan Has Type-2 Genotype . Iranian Journal of Parasitology . 17 . 1 . 43–52 . 10.18502/ijpa.v17i1.9015 . 1735-7020 . 9375727 . 36046566.
  45. News: Jayanth . A. S. . 2024-06-30 . Unhygienic water, mercury rise may be behind ‘brain-eating amoeba’ cases in Kerala . 2024-08-16 . The Hindu . en-IN . 0971-751X.
  46. News: 2024-07-23 . 6 brain-eating amoeba cases in a year . 2024-08-16 . The Times of India . 0971-8257.